Compare ZTO & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZTO | WST |
|---|---|---|
| Founded | 2002 | 1923 |
| Country | China | United States |
| Employees | 23399 | N/A |
| Industry | Advertising | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.3B | 18.5B |
| IPO Year | N/A | 2004 |
| Metric | ZTO | WST |
|---|---|---|
| Price | $24.95 | $299.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 7 |
| Target Price | $23.65 | ★ $325.86 |
| AVG Volume (30 Days) | ★ 1.1M | 861.6K |
| Earning Date | 05-19-2026 | 04-23-2026 |
| Dividend Yield | ★ 2.72% | 0.30% |
| EPS Growth | N/A | ★ 1.49 |
| EPS | N/A | ★ 1.92 |
| Revenue | N/A | ★ $2,886,900,000.00 |
| Revenue This Year | $14.01 | $6.76 |
| Revenue Next Year | $9.12 | $6.22 |
| P/E Ratio | ★ $21.83 | $156.47 |
| Revenue Growth | N/A | ★ 1.95 |
| 52 Week Low | $16.68 | $203.74 |
| 52 Week High | $26.20 | $322.34 |
| Indicator | ZTO | WST |
|---|---|---|
| Relative Strength Index (RSI) | 48.45 | 68.17 |
| Support Level | $23.18 | $234.43 |
| Resistance Level | $25.90 | $321.34 |
| Average True Range (ATR) | 0.46 | 8.28 |
| MACD | -0.07 | 1.27 |
| Stochastic Oscillator | 15.70 | 64.03 |
ZTO Express is China's largest express delivery company by parcel volume, with a volume share of 19.4% in 2024. It operates a network partner model where it provides line-haul transportation and sorting services, while its local network partners provide first-mile pickup and last-mile delivery services under the ZTO brand name. Headquartered in Shanghai, the company was founded in 2002 by Meisong Lai, who remains chair, CEO, and its major shareholder with 78% voting rights as of March 31, 2025. ZTO's strategic shareholder is leading China e-commerce company Alibaba Group with around an 8.9% interest.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.